Search

GE HealthCare Technologies

Closed

SectorHealthcare

63.47 -0.91

Overview

Share price change

24h

Current

Min

63.48

Max

64.62

Key metrics

By Trading Economics

Income

163M

574M

Sales

164M

5.3B

P/E

Sector Avg

15.866

56.597

EPS

1.13

Dividend yield

0.2

Profit margin

10.84

Employees

54,000

EBITDA

198M

953M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+23.07% upside

Dividends

By Acuity

Dividend yield

Sector Avg

0.20%

2.18%

Next Earnings

28 Oct 2026

Next Dividend date

13 Nov 2026

Next Ex Dividend date

23 Oct 2026

Market Stats

By TradingEconomics

Market Cap

3.3B

31B

Previous open

64.38

Previous close

63.47

News Sentiment

By Acuity

30%

70%

54 / 339 Healthcare

GE HealthCare Technologies Chart

Past performance is not a reliable indicator of future results.

Related News

15 Sept 2026, 22:51 UTC

Shares of GE Healthcare Technologies rose in after-market hours, despite broader market uncertainties following a notable decline in the NY Empire State Manufacturing Index.

14 Sept 2026, 23:31 UTC

GE Healthcare Technologies shares are higher in after-market trading, despite unusual activity earlier in the session and remaining below the 20-day moving average.

11 Sept 2026, 20:08 UTC

GE Healthcare Technologies is lower today, continuing a seven-session decline. The stock is trading significantly below its 20-day moving average.

10 Sept 2026, 23:11 UTC

GE Healthcare Technologies shares are higher in after-market trading following Thursday's close, despite being below the 20-day moving average and recent declines.

9 Sept 2026, 19:56 UTC

GE Healthcare Technologies shares are lower, continuing a five-session decline amid broader market pressures and rising crude oil prices raising inflation concerns.

8 Sept 2026, 23:01 UTC

GE Healthcare Technologies shares are higher in after-market trading, advancing modestly since Tuesday's close despite being below its 20-day moving average.

4 Sept 2026, 20:08 UTC

Shares of GE Healthcare Technologies are lower today, continuing a decline since Thursday's close amid broader market selling pressure following a strong jobs report.

3 Sept 2026, 20:07 UTC

News

GE Healthcare Technologies received CE Mark approval for its Photonova Spectra CT system, but shares are trading lower during Thursday's session.

2 Sept 2026, 23:06 UTC

GE Healthcare Technologies shares are higher in after-market trading, reflecting a modest gain since Wednesday's close, despite settling lower earlier in the session.

1 Sept 2026, 23:01 UTC

GE Healthcare Technologies shares are higher in after-market hours, reflecting a recovery after a week of lower closes. No specific news was identified.

31 Aug 2026, 19:46 UTC

GE Healthcare Technologies is lower amid broader market unease following hawkish comments from Federal Reserve Chair Kevin Warsh, raising interest rate hike expectations.

28 Aug 2026, 22:06 UTC

GE Healthcare Technologies shares are higher in after-market hours, despite no specific news and recent declines in the last five sessions.

27 Aug 2026, 23:02 UTC

Shares of GE Healthcare Technologies Inc. are lower in after-market hours, continuing a trend of declines over the past four sessions.

26 Aug 2026, 23:06 UTC

GE Healthcare Technologies shares are lower in after-market trading, continuing a downward trend observed over the past four sessions amid persistent inflationary pressures.

25 Aug 2026, 19:46 UTC

GE Healthcare Technologies is trading lower today, reflecting a modest decline since Monday's close. The stock remains near the upper end of its one-month range.

24 Aug 2026, 23:36 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting a slight increase since Monday's close and strong monthly performance.

19 Aug 2026, 20:06 UTC

News

GE Healthcare Technologies appointed William Grogan as CFO, effective September 2026. BTIG reiterated its Buy rating with a $79 price target. Shares are higher since Tuesday's close.

18 Aug 2026, 23:51 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, reaching above Tuesday's close despite elevated bond yields and ongoing inflation concerns.

17 Aug 2026, 23:11 UTC

GE Healthcare Technologies shares are higher in after-market trading, reaching a notable increase while remaining above its 20-day moving average. No specific news was identified.

14 Aug 2026, 19:46 UTC

GE Healthcare Technologies is trading roughly flat, with no specific news identified. Shares peaked earlier but have since settled back down.

13 Aug 2026, 23:46 UTC

GE Healthcare Technologies shares declined in after-market trading, reflecting a slight drop since Thursday's close. The stock remained above its 20-day moving average.

12 Aug 2026, 23:26 UTC

News

Trian Fund Management increased its stake in GE Healthcare Technologies to 3.1 million shares, contributing to a modest rise in after-market hours.

11 Aug 2026, 20:06 UTC

GE Healthcare Technologies shares are lower today amid broader market declines. The stock remains above its 20-day moving average despite earlier gains.

10 Aug 2026, 19:16 UTC

GE Healthcare Technologies shares are higher today, reflecting gains since Friday's close. No specific news was identified to explain the price movement.

7 Aug 2026, 23:36 UTC

No specific news for GE Healthcare Technologies. The stock traded roughly flat after-market, remaining near the upper end of its one-month range.

6 Aug 2026, 19:46 UTC

GE Healthcare Technologies remains roughly flat as price fluctuations continue. The stock trades near the upper end of its one-month range and above its moving average.

5 Aug 2026, 19:56 UTC

News

GE Healthcare reported strong Q2 results with $5.30 billion in revenue and adjusted EPS of $1.13, but shares are trading lower since Tuesday's close.

4 Aug 2026, 23:41 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting unusual activity and remaining above the 20-day moving average.

3 Aug 2026, 23:01 UTC

Shares of GE Healthcare Technologies declined after-market, continuing a downward trend since Monday's close amid broader market conditions.

31 Jul 2026, 23:16 UTC

News

Shares of GE Healthcare Technologies are lower in after-market trading following UBS's Neutral rating and a price target increase to $73.

Peer Comparison

Price change

GE HealthCare Technologies Forecast

Price Target

By TipRanks

23.07% upside

12 Months Forecast

Average 79.071 USD  23.07%

High 92 USD

Low 70 USD

Based on 14 Wall Street analysts offering 12 month price targets forGE HealthCare Technologies - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

14 ratings

9

Buy

5

Hold

0

Sell

Sentiment

By Acuity

54 / 339 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.
help-icon Live chat